Which has grown faster, CRL or HIMS?

Over the past five years, HIMS grew revenue faster — CRL at a 5.77% CAGR versus HIMS at 69.19%.

Which has been the better investment, CRL or HIMS?

Over the past 5-year, HIMS delivered the higher annualized total return — CRL at 8.26% versus HIMS at 17.04%. Past performance doesn't predict future results.

Charles River Laboratories International, Inc. (CRL) vs Hims & Hers Health, Inc. (HIMS)

CRL leads on 7 of 12 compared metrics.

A side-by-side comparison of Charles River Laboratories International, Inc. and Hims & Hers Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

CRL

Charles River Laboratories International, Inc.

$9.03B

$187.51Healthcare

HIMS

Hims & Hers Health, Inc.

$5.98B

$26.82Healthcare

Total return — CRL vs HIMS

growth of $100 · last 7y

CRL +39.6%HIMS +173.7%HIMS compounded faster

CRL HIMS

CRL vs HIMS: by the numbers

•CRL is the larger company ($9.03B vs $5.98B market cap).
•Both run net losses; HIMS's is the smaller (-0.56% vs -4.59% net margin).
•HIMS grew revenue faster over the past five years (69.19% vs 5.77% CAGR).

Which is better, CRL or HIMS?

Metric tally: CRL 7 · HIMS 5

It depends on what you're optimizing for:

GrowthHIMS(faster 5Y revenue CAGR)

QualityCRL(higher ROIC)

Valuation

Metric	CRL	HIMS
Forward P/E	15.21●	56.93
P/S ratio	2.28●	2.58
P/B ratio	3.12●	13.73
EV / EBITDA	41.45●	234.03
FCF yield	4.26%●	1.24%

Profitability

Metric	CRL	HIMS
Gross margin	31.86%	67.64%●
Operating margin	11.77%●	1.32%
Net margin	-4.59%	-0.56%●
ROE	-6.28%	-2.97%●
ROIC	8.36%●	6.02%

Growth (annualized)

Metric	CRL	HIMS
Revenue CAGR (5Y)	5.77%	69.19%●
EPS CAGR (5Y)	-40.99%	—
FCF CAGR (5Y)	-3.98%	—
Total return CAGR (5Y)	-11.83%	17.04%●

Frequently asked

Which is better, CRL or HIMS?: It depends on your goal. growth: HIMS (faster 5Y revenue CAGR); quality: CRL (higher ROIC). Across all compared metrics, CRL leads 7 to 5.
Which has grown faster, CRL or HIMS?: Over the past five years, HIMS grew revenue faster — CRL at a 5.77% CAGR versus HIMS at 69.19%.
Which has been the better investment, CRL or HIMS?: Over the past 5-year, HIMS delivered the higher annualized total return — CRL at 8.26% versus HIMS at 17.04%. Past performance doesn't predict future results.

Go deeper

Full CRL analysis Full HIMS analysis Interactive comparison tool

Dig into the metrics

Charles River Laboratories International P/E ratio Hims & Hers Health P/E ratio Charles River Laboratories International dividend yield Hims & Hers Health dividend yield Charles River Laboratories International ROE Hims & Hers Health ROE Charles River Laboratories International operating margin Hims & Hers Health operating margin Charles River Laboratories International revenue growth Hims & Hers Health revenue growth Charles River Laboratories International free cash flow Hims & Hers Health free cash flow

Charles River Laboratories International & Hims & Hers Health appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.